Azimilidina Pharmaceutical composition comprising 0.5 to 2.5 (W / W) of water; and use for the treatment of Cardiac arrhythmias.

摘要

The present invention is directed to solvates and various polymorphic forms of (E)-1-[[[5-(4-chlorophenyl)-2-furanyl]methylene]amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidinedione dihydrochloride and pharmaceutical compositions thereof.